Nutrition, inflammation and liver-spleen axis

Critical Reviews in Food Science and Nutrition

Volumn 58, Issue 18, 2018, Pages 3141-3158

  Barrea, Luigi ^a   Di Somma, Carolina ^b   Muscogiuri, Giovanna ^a   Tarantino, Giovanni ^c   Tenore, Gian Carlo ^d   Orio, Francesco ^e,f   Colao, Annamaria ^c   Savastano, Silvia ^c  

^a IOS and COLEMAN Srl   (Italy)

^b IRCCS SDN   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^f NONE   (Italy)

Author keywords

Diet; Inflammation; ; Liver spleen Axis; ; Nutrition; Nutritionist

Indexed keywords

DISEASES; PATHOLOGY; VITAMINS;

GENETIC SUSCEPTIBILITY; GLUCAGON-LIKE PEPTIDE-1; INFLAMMATION; INFLAMMATORY RESPONSE; NON-ALCOHOLIC FATTY LIVER DISEASE; NUTRITIONAL EPIDEMIOLOGY; NUTRITIONIST; SYSTEMIC INFLAMMATION;

NUTRITION;

TRACE ELEMENT; VITAMIN D;

DIET; FOOD QUALITY; GENETIC PREDISPOSITION; GENETICS; HEALTHY DIET; HUMAN; IMMUNOLOGY; INFLAMMATION; INTESTINE FLORA; LIVER; MEDITERRANEAN DIET; NONALCOHOLIC FATTY LIVER; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PHYSIOLOGY; SPLEEN; SPLENOMEGALY;

DIET; DIET, MEDITERRANEAN; FOOD QUALITY; GASTROINTESTINAL MICROBIOME; GENETIC PREDISPOSITION TO DISEASE; HEALTHY DIET; HUMANS; INFLAMMATION; LIVER; MICRONUTRIENTS; NON-ALCOHOLIC FATTY LIVER DISEASE; NUTRITIONAL STATUS; SPLEEN; SPLENOMEGALY; VITAMIN D;

EID: 85061573880     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2017.1353479     Document Type: Review

References (216)

1. Abenavoli, L., M., Greco, I., Nazionale, V., Peta, N., Milic, F., Accattato, D., Foti, E., Gulletta, and F., Luzza. 2015. Effects of Mediterranean diet supplemented with silybin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol 9:519–27.
2. Abenavoli, L., N., Milic, V., Peta, F., Alfieri, A., De Lorenzo, and S., Bellentani. 2014. Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet. World J Gastroenterol 20:16831–40.
3. Aharoni, S., Y., Lati, M., Aviram, and B., Fuhrman. 2015. Pomegranate juice polyphenols induce a phenotypic switch in macrophage polarization favoring a M2 anti-inflammatory state. Biofactors 41:44–51.
4. Aller, R., O., Izaola, B., de la Fuente, and D. A., De Luis Román. 2015. Mediterranean diet is associated with liver histology in patients with non alcoholic fatty liver disease. Nutr Hosp 32:2518–24.
5. Aravindhan, V., and H., Madhumitha. 2016. Metainflammation in diabetic coronary artery disease: Emerging role of innate and adaptive immune responses. J Diabetes Res 2016:6264149.
6. Bach-Faig, A., C., Fuentes-Bol, D., Ramos, J. L., Carrasco, B., Roman, I. F., Bertomeu, E., Cristià, D., Geleva, and L., Serra-Majem. 2011. The mediterranean diet in Spain: Adherence trends during the past two decades using the Mediterranean Adequacy Index. Public Health Nutr 14:622–8.
7. Baeck, C., and F., Tacke. 2014. Balance of inflammatory pathways and interplay of immune cells in the liver during homeostasis and injury. EXCLI J 13:67–81.
8. Baggio, L. L., and D. J., Drucker. 2007. Biology of incretins: GLP-1 and GIP. Gastroenterology 132:2131–57.
9. Balato, N., M., Napolitano, F., Ayala, C., Patruno, M., Megna, and G., Tarantino. 2015. Nonalcoholic fatty liver disease, spleen and psoriasis: New aspects of low-grade chronic inflammation. World J Gastroenterol 21:6892–7.
10. Barrea, L., N., Balato, C., Di Somma, P. E., Macchia, M., Napolitano, M. C., Savanelli, K., Esposito, A., Colao, and S., Savastano. 2015a. Nutrition and psoriasis: is there any association between the severity of the disease and adherence to the Mediterranean diet? J Transl Med 13:18.
11. Barrea, L., P. E., Macchia, G., Tarantino, Di Somma, C., E., Pane, N., Balato, M., Napolitano, A., Colao, and S., Savastano. 2015b. Nutrition: a key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire. J Transl Med 13:303.
12. Barrea, L., G., Muscogiuri, P. E., Macchia, C., Di Somma, A., Falco, M. C., Savanelli, A., Colao, and S., Savastano. 2017a. Mediterranean diet and phase angle in a sample of adult population: Results of a pilot study. Nutrients 9:151–64.
13. Barrea, L., F., Nappi, C., Di Somma, M. C., Savanelli, A., Falco, A., Balato, N., Balato, and S., Savastano. 2016a. Environmental risk factors in psoriasis: The point of view of the nutritionist. Int J Environ Res Public Health 13:743–54.
14. Barrea, L., M. C., Savanelli, C., Di Somma, M., Napolitano, M., Megna, A., Colao, and S., Savastano. 2017b. Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist. Rev Endocr Metab Disord 18:195–205.
15. Barrea, L., S., Savastano, C., Di Somma, M. C., Savanelli, F., Nappi, L., Albanese, F., Orio, and A., Colao. 2016b. Low serum vitamin D-status, air pollution and obesity: A dangerous liaison. Rev Endocr Metab Disord 18:207–14.
16. Bellentani, S. 2017. The epidemiology of non-alcoholic fatty liver disease. Liver Int 37:81–84.
17. Berg, A. H., Y., Lin, M. P., Lisanti, and P. E., Scherer. 2004. Adipocyte differentiation induces dynamic changes in NF-kappaB expression and activity. Am J Physiol Endocrinol Metab 287:E1178–88.
18. Berzigotti, A., S., Seijo, E., Reverter, and J., Bosch. 2013. Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol 7:141–55.
19. Bo, S., G., Ciccone, S., Guidi, R., Gambino, M., Durazzo, L., Gentile, M., Cassader, P., Cavallo-Perin, and G., Pagano. 2008. Diet or exercise: what is more effective in preventing or reducing metabolic alterations? Eur J Endocrinol 159:685–91.
20. Bozzetto, L., A., Prinster, G., Annuzzi, L., Costagliola, A., Mangione, A., Vitelli, R., Mazzarella, M., Longobardo, M., Mancini, C., Vigorito, G., Riccardi, and A. A., Rivellese. 2012. Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients. Diabetes Care 35:1429–35.
21. Bronte, V., and M. J., Pittet. 2013. The spleen in local and systemic regulation of immunity. Immunity 39:806–18.
22. Bullock, B. P., R. S., Heller, and J. F., Habener. 1996. Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology 137:2968–78.
23. Burdge, G. C., and P. C., Calder. 2005. Plasma cytokine response during the postprandial period: a potential causal process in vascular disease? Br J Nutr 93:3–9.
24. Buyken, A. E., V., Flood, M., Empson, E., Rochtchina, A. W., Barclay, J., Brand-Miller, and P., Mitchell. 2010. Carbohydrate nutrition and inflammatory disease mortality in older adults. Am J Clin Nutr 92:634–43.
25. Buyken, A. E., J., Goletzke, G., Joslowski, A., Felbick, G., Cheng, C., Herder, and J. C., Brand-Miller. 2014. Association between carbohydrate quality and inflammatory markers: systematic review of observational and interventional studies. Am J Clin Nutr 99:813–33.
26. Buzzetti, E., M., Pinzani, and E. A., Tsochatzis. 2016. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 65:1038–48.
27. Cai, D., M., Yuan, D. F., Frantz, P. A., Melendez, L., Hansen, J., Lee, and S. E., Shoelson. 2005. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 11:183–90.
28. Calder, P. C., P., Yaqoob, F., Thies, F. A., Wallace, and E. A., Miles. 2002. Fatty acids and lymphocyte functions. Br J Nutr 87:S31–48.
29. Calder, P. C., 2015. Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. Biochim Biophys Acta 1851:469–84.
30. Cancello, R., J., Tordjman, C., Poitou, G., Guilhem, J. L., Bouillot, D., Hugol, C., Coussieu, A., Basdevant, A., Bar Hen, P., Bedossa, M., Guerre-Millo, and K., Clément. 2006. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 55:1554–61.
31. Cani, P. D., J., Amar, M. A., Iglesias, M., Poggi, C., Knauf, D., Bastelica, A. M., Neyrinck, F., Fava, K. M., Tuohy, C., Chabo, A., Waget, E., Delmée, B., Cousin, T., Sulpice, B., Chamontin, J., Ferrières, J. F., Tanti, G. R., Gibson, L., Casteilla, N. M., Delzenne, M. C., Alessi, and R., Burcelin. 2007. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:1761–72.
32. Cani, P. D., R., Bibiloni, C., Knauf, A., Waget, A. M., Neyrinck, N. M., Delzenne, and R., Burcelin. 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57:1470–81.
33. Casas, R., E., Sacanella, M., Urpí-Sardà, G., Chiva-Blanch, E., Ros, M. A., Martínez-González, M. I., Covas, L.-R., Rosa Ma, J., Salas-Salvadó, M., Fiol, F., Arós, and R., Estruch. 2014. The effects of the mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial. PLoS One 9:1–11.
34. Chacko, S. A., Y., Song, L., Nathan, L., Tinker, I. H., de Boer, F., Tylavsky, R., Wallace, and S., Liu. 2010. Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women. Diabetes Care 33:304–10.
35. Chan, D. C., J., Pang, G., Romic, and G. F., Watts. 2013. Postprandial hypertriglyceridemia and cardiovascular disease: Current and future therapies. Curr Atheroscler Rep 15309.
36. Chan, R., V. W., Wong, W. C., Chu, G. L., Wong, L. S., Li, J., Leung, A. M., Chim, D. K., Yeung, M. M., Sea, J., Woo, F. K., Chan, and H. L., Chan. 2015. Diet-quality scores and prevalence of nonalcoholic fatty liver disease: A population study using proton-magnetic resonance spectroscopy. PLoS One 10:e0139310.
37. Chaudhary, D. P., R., Sharma, and D. D., Bansal. 2010. Implications of magnesium deficiency in type 2 diabetes: A review. Biol Trace Elem Res 134:119–29.
38. Chawla, A., K. D., Nguyen, and Y. P., Goh. 2011. Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol 11:738–49.
39. Chen, P. M., K. J., Liu, P. J., Hsu, C. F., Wei, C. H., Bai, L. J., Ho, H. K., Sytwu, and B. L., Yen. 2014. Induction of immunomodulatory monocytes by human mesenchymal stem cell-derived hepatocyte growth factor through ERK1/2. J Leukoc Biol 96:295–303.
40. Cipolletta, D. 2014. Adipose tissue-resident regulatory T cells: phenotypic specialization, functions and therapeutic potential. Immunolog.142:517–25.
41. Cobbina, E., and F., Akhlaghi. 2017. Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters. Drug Metab Rev 17:1–15.
42. Cordain, L., S. B., Eaton, A., Sebastian, N., Mann, S., Lindeberg, B. A., Watkins, J. H., O'Keefe, and J., Brand-Miller. 2005. Origins and evolution of the Western diet: Health implications for the 21st century. Am J Clin Nutr 81:341–54.
43. Cuervo, A., L., Valdés, N., Salazar, C. G., de los Reyes-Gavilán, P., Ruas-Madiedo, M., Gueimonde, and S., González. 2014. Pilot study of diet and microbiota: interactive associations of fibers and polyphenols with human intestinal bacteria. J Agric Food Chem 62:5330–6.
44. D'Alessandro, A., and G., De Pergola. 2015. Mediterranean diet and cardiovascular disease: A critical evaluation of a priori dietary indexes. Nutrients 7:7863–88.
45. D'Alessio, D., 2008. Intestinal hormones and regulation of satiety: The case for CCK, GLP-1, PYY, and Apo A-IV. JPEN J Parenter Enteral Nutr 32:567–8.
46. de Jong, P. R., J. M., González-Navajas, and N. J., Jansen. 2016. The digestive tract as the origin of systemic inflammation. Crit Care 20:279.
47. de Vries, M. A., B., Klop, S. A., Eskes, T. L., van der Loos, F. J., Klessens-Godfroy, J., Wiebolt, H. W., Janssen, E. M., Westerman, and M., Castro Cabezas. 2014. The postprandial situation as a pro-inflammatory condition. Clin Investig Arterioscler 26:184–92.
48. Deceuninck, Y., E., Bichon, P., Marchand, C. Y., Boquien, A., Legrand, C., Boscher, J. P., Antignac, and B., Le Bizec. 2015. Determination of bisphenol A and related substitutes/analogues in human breast milk using gas chromatography-tandem mass spectrometry. Anal. Bioanal. Chem 407:2485–97.
49. Diamanti-Kandarakis, E., O., Papalou, E. A., Kandaraki, and G., Kassi. 2017. MECHANISMS IN ENDOCRINOLOGY: Nutrition as a mediator of oxidative stress in metabolic and reproductive disorders in women. Eur J Endocrinol 176:R79–99.
50. Dibaba, D. T., P., Xun, and K., He. 2014. Dietary magnesium intake is inversely associated with serum C-reactive protein levels: Meta-analysis and systematic review. Eur J Clin Nutr 68:510–6.
51. Duleba, A. J., and A., Dokras. 2012. Is PCOS an inflammatory process? Fertil Steril 97:7–12
52. Dumas, M. E., R. H., Barton, A., Toye, O., Cloarec, C., Blancher, A., Rothwell, J., Fearnside, R., Tatoud, V., Blanc, J. C., Lindon, S. C., Mitchell, E., Holmes, M. I., McCarthy, J., Scott, D., Gauguier, and J. K., Nicholson. 2006. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci U S A 103:12511–6.
53. Elangovan, H., S., Chahal, and J. E., Gunton. 2017. Vitamin D in liver disease: Current evidence and potential directions. Biochim Biophys Acta S0925-4439:30003–0.
54. Eliades, M., E., Spyrou, N., Agrawal, M., Lazo, F. L., Brancati, J. J., Potter, A. A., Koteish, J. M., Clark, E., Guallar, and R., Hernaez. 2013. Meta-analysis: Vitamin D and non-alcoholic fatty liver disease. Aliment Pharmacol Ther 38:246–54.
55. Eriksson, J. G., 2016. Developmental origins of health and disease - from a small body size at birth to epigenetics. Ann Med 48:456–67.
56. Esposito, K., and D., Giugliano. 2006. Diet and inflammation: a link to metabolic and cardiovascular diseases. Eur Heart J 27:15–20.
57. Esposito, K., F., Nappo, R., Marfella, G., Giugliano, F., Giugliano, M., Ciotola, L., Quagliaro, A., Ceriello, and D., Giugliano. 2002. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: Role of oxidative stress. Circulation 106:2067–72.
58. Esposito, K., A., Pontillo, F., Giugliano, G., Giugliano, R., Marfella, G., Nicoletti, and D., Giugliano. 2003. Association of low interleukin-10 levels with the metabolic syndrome in obese women. J Clin Endocrinol Metab 88:1055–8.
59. Fardet, A., 2010. New hypotheses for the health-protective mechanisms of whole-grain cereals: What is beyond fibre? Nutr Res Rev 23:65–134.
60. Feliciano Pereira, P., C., das Graças de Almeida, and C., Alfenas Rde. 2014. Glycemic index role on visceral obesity, subclinical inflammation and associated chronic diseases. Nutr Hosp 30:237–43.
61. Ferolla, S. M., L. C., Silva, L., Ferrari Mde, A. S., da Cunha, S., Martins Fdos, C. A., Couto, and T. C., Ferrari. 2015. Dietary approach in the treatment of nonalcoholic fatty liver disease. World J Hepatol 7:2522–34.
62. Finelli, C., and G., Tarantino. 2012. Is there any consensus as to what diet or lifestyle approach is the right one for NAFLD patients? J Gastrointestin Liver Dis 21:293–302.
63. Galland, L., 2010. Diet and inflammation. Nutr Clin Pract 25:634–40.
64. Ganz, M., and G., Szabo. 2013. Immune and inflammatory pathways in NASH. Hepatol Int 7:771–81.
65. Gao, B., W. I., Jeong, and Z., Tian. 2008. Liver: An organ with predominant innate immunity. Hepatology 47:729–36.
66. Georgoulis, M., M. D., Kontogianni, A., Margariti, D., Tiniakos, E., Fragopoulou, R., Zafiropoulou, and G., Papatheodoridis. 2015. Associations between dietary intake and the presence of the metabolic syndrome in patients with non-alcoholic fatty liver disease. J Hum Nutr Diet 28:409–15.
67. Golshani-Hebroni, S., 2016. Mg (++) requirement for MtHK binding, and Mg (++) stabilization of mitochondrial membranes via activation of MtHK & MtCK and promotion of mitochondrial permeability transition pore closure: A hypothesis on mechanisms underlying Mg(++)’s antioxidant and cytoprotective effects. Gene 581:1–13.
68. Gommers, L. M., J. G., Hoenderop, R. J., Bindels, and J. H., de Baaij. 2016. Hypomagnesemia in type 2 diabetes: A vicious circle? Diabetes 65:3–13.
69. Gonçalves de Carvalho, C. M., and S. M., Ribeiro. 2016. Aging, low-grade systemic inflammation and vitamin D: A mini-review. Eur J Clin Nutr 71:434–40.
70. Gotoh, K., M., Inoue, T., Masaki, S., Chiba, T., Shimasaki, H., Ando, K., Fujiwara, I., Katsuragi, T., Kakuma, M., Seike, T., Sakata, and H., Yoshimatsu. 2012. A novel anti-inflammatory role for spleen-derived interleukin-10 in obesity-induced inflammation in white adipose tissue and liver. Diabetes 61:1994–2003.
71. Greenberg, A. S., and M. S., Obin. 2006. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 83:461S–5S.
72. Gupta, N. A., J., Mells, R. M., Dunham, A., Grakoui, J., Handy, N. K., Saxena, and F. A., Anania. 2010. Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway. Hepatology 51:1584–92.
73. Güray, U., A. R., Erbay, Y., Güray, M. B., Yilmaz, A. A., Boyaci, H., Sasmaz, S., Korkmaz, and E., Kütük. 2004. Levels of soluble adhesion molecules in various clinical presentations of coronary atherosclerosis. Int J Cardiol 96:235–40.
74. Hadjiyanni, I., K. A., Siminovitch, J. S., Danska, and D. J., Drucker. 2010. Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells. Diabetologia 53:730–40.
75. Haghighatdoost, F., A., Salehi-Abargouei, P. J., Surkan, and L., Azadbakht. 2016. The effects of low carbohydrate diets on liver function tests in nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials. J Res Med Sci 21:53.
76. Halliwell, B., and J. M. C., Gutteridge. 1999. Free radicals in biology and medicine. 3rd ed. In: Oxford, UK: Oxford University Press. p.980.
77. Harvey, K. A., T., Arnold, T., Rasool, C., Antalis, S. J., Miller, and R. A., Siddiqui. 2008. Trans-fatty acids induce pro-inflammatory responses and endothelial cell dysfunction. Br J Nutr 99:723–31.
78. Hauck, A. K., and D. A., Bernlohr. 2016. Oxidative stress and lipotoxicity. J Lipid Res 57:1976–86.
79. Hemalatha, R., 2013. Diet induced inflammation and potential consequences on fetal development. J Nutr Disorders Ther 3:125.
80. Herieka, M., and C., Erridge. 2014. High-fat meal induced postprandial inflammation. Mol Nutr Food Res 58:136–46.
81. Holst, J. J., 2007. The physiology of glucagon-like peptide 1. Physiol Rev 87:1409–39.
82. Hotamisligil, G. S., 2006. Inflammation and metabolic disorders. Nature 444:860–7.
83. Huang, W., A., Metlakunta, N., Dedousis, P., Zhang, I., Sipula, J. J., Dube, D. K., Scott, and R. M., O'Doherty. 2010. Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance. Diabetes 59:347–57.
84. Inoue, M., K., Gotoh, M., Seike, T., Masaki, K., Honda, T., Kakuma, and H., Yoshimatsu. 2012. Role of the spleen in the development of steatohepatitis in high-fat-diet-induced obese rats. Exp Biol Med (Maywood) 237:461–70.
85. Jacobs, D. R., and L. C., Tapsell. 2013. Food synergy: The key to a healthy diet. Proc Nutr Soc 72:200–6.
86. Jaudszus, A., M., Gruen, B., Watzl, C., Ness, A., Roth, A., Lochner, D., Barz, H., Gabriel, M., Rothe, and G., Jahreis. 2013. Evaluation of suppressive and pro-resolving effects of EPA and DHA in human primary monocytes and T-helper cells. J Lipid Res 54:923–35.
87. Jegatheesan, P., and J. P., De Bandt. 2017. Fructose and NAFLD: The multifaceted aspects of fructose metabolism. Nutrients 9:230–42.
88. Jiao, J., J. Y., Xu, W., Zhang, S., Han, and L. Q., Qin. 2015. Effect of dietary fiber on circulating C-reactive protein in overweight and obese adults: a meta-analysis of randomized controlled trials. Int J Food Sci Nutr 66:114–9.
89. Juárez-Hernández, E., N. C., Chávez-Tapia, M., Uribe, and V. J., Barbero-Becerra. 2016. Role of bioactive fatty acids in nonalcoholic fatty liver disease. Nutr J 15:72.
90. Kanherkar, R. R., N., Bhatia-Dey, and A. B., Csoka. 2014. Epigenetics across the human lifespan. Front Cell Dev Biol 2:49.
91. Karpe, F., J. R., Dickmann, and K. N., Frayn. 2011. Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 60:2441–9.
92. Kennedy, A., K., Martinez, C. C., Chuang, K., LaPoint, and M., McIntosh. 2009. Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: Mechanisms of action and implications. J Nutr 139:1–4.
93. Khoo, A. L., L. Y., Chai, H. J., Koenen, F. C., Sweep, I., Joosten, M. G., Netea, and A. J., van der Ven. 2011a. Regulation of cytokine responses by seasonality of vitamin D status in healthy individuals. Clin Exp Immunol 164:72–9.
94. Khoo, A. L., I., Joosten, M., Michels, R., Woestenenk, F., Preijers, X. H., He, M. G., Netea, A. J., van der Ven, and H. J., Koenen. 2011b. 1,25-Dihydroxyvitamin D3 inhibits proliferation but not the suppressive function of regulatory T cells in the absence of antigen-presenting cells. Immunology 134:459–68.
95. Kim, C. H., 2010. Homeostatic and pathogenic extramedullary hematopoiesis. J Blood Med 1:13–9.
96. Kim, J. B., 2016. Dynamic cross talk between metabolic organs in obesity and metabolic diseases. Exp Mol Med 48:e214.
97. Kim, J. M., J. P., Rasmussen, and A. Y., Rudensky. 2007. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 8:191–7.
98. Kim, M. S., M. S., Choi, and S. N., Han. 2011. High fat diet-induced obesity leads to proinflammatory response associated with higher expression of NOD2 protein. Nutr Res Pract 5:219–23.
99. King, D. E., A. G., Mainous, M. E., Geesey, and R. F., Woolson. 2005. Dietary magnesium and C-reactive protein levels. J Am Coll Nutr 24:166–71.
100. Kitabchi, A. E., K. A., McDaniel, J. Y., Wan, F. A., Tylavsky, C. A., Jacovino, C. W., Sands, E. A., Nyenwe, and F. B., Stentz. 2013. Effects of high-protein versus high-carbohydrate diets on markers of β-cell function, oxidative stress, lipid peroxidation, proinflammatory cytokines, and adipokines in obese, premenopausal women without diabetes: A randomized controlled trial. Diabetes Care 36:1919–25.
101. Klonoff, D. C., J. B., Buse, L. L., Nielsen, X., Guan, C. L., Bowlus, J. H., Holcombe, M. E., Wintle, and D. G., Maggs. 2008. Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years. Curr Med Res Opin 24:275–86.
102. Kontogianni, M. D., N., Tileli, A., Margariti, M., Georgoulis, M., Deutsch, D., Tiniakos, E., Fragopoulou, R., Zafiropoulou, Y., Manios, and G., Papatheodoridis. 2014. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease. Clin Nutr 33:678–83.
103. Koo, S. H., 2013. Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis. Clin Mol Hepatol 19:210–5.
104. Kromhout, D., and J., de Goede. 2014. Update on cardiometabolic health effects of ω-3 fatty acids. Curr Opin Lipidol 25:85–90.
105. Laugerette, F., C., Vors, N., Peretti, and M. C., Michalski. 2011. Complex links between dietary lipids, endogenous endotoxins and metabolic inflammation. Biochimie 93:39–45.
106. Lee, J. H., C., Wang, and C. H., Kim. 2009. FoxP3+ regulatory T cells restrain splenic extramedullary myelopoiesis via suppression of hemopoietic cytokine-producing T cells. J Immunol 183:6377–86.
107. Lee, J. Y., K. H., Sohn, S. H., Rhee, and D., Hwang. 2001. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem 276:16683–9.
108. Lee, Y. S., and H. S., Jun. 2016. Anti-inflammatory effects of GLP-1-based therapies beyond glucose control. Mediators Inflamm 2016:3094642.
109. Levitan, E. B., N. R., Cook, M. J., Stampfer, P. M., Ridker, K. M., Rexrode, J. E., Buring, J. E., Manson, and S., Liu. 2008. Dietary glycemic index, dietary glycemic load, blood lipids, and C-reactive protein. Metabolism 57:437–43.
110. L'homme, L., N., Esser, L., Riva, A., Scheen, N., Paquot, J., Piette, and S., Legrand-Poels. 2013. Unsaturated fatty acids prevent activation of NLRP3 inflammasome in human monocytes/macrophages. J Lipid Res 54:2998–3008.
111. Liu, W., R. D., Baker, T., Bhatia, L., Zhu, and S. S., Baker. 2016. Pathogenesis of nonalcoholic steatohepatitis. Cell Mol Life Sci 73:1969–87.
112. Lund, A., F. K., Knop, and T., Vilsbøll. 2011. Emerging GLP-1 receptor agonists. Expert Opin Emerg Drugs 16:607–18.
113. Lundman, P., S., Boquist, A., Samnegård, M., Bennermo, C., Held, C. G., Ericsson, A., Silveira, A., Hamsten, and P., Tornvall. 2007. A high-fat meal is accompanied by increased plasma interleukin-6 concentrations. Nutr Metab Cardiovasc Dis 17:195–202.
114. Ma, Y., J. A., Griffith, L., Chasan-Taber, B. C., Olendzki, E., Jackson, E. J., Stanek, W., Li, S. L., Pagoto, A. R., Hafner, and I. S., Ockene. 2006. Association between dietary fiber and serum C-reactive protein. Am J Clin Nutr 83:760–6.
115. Ma, Y., J. R., Hébert, W., Li, E. R., Bertone-Johnson, B., Olendzki, S. L., Pagoto, L., Tinker, M. C., Rosal, I. S., Ockene, J. K., Ockene, J. A., Griffith, and S., Liu. 2008. Association between dietary fiber and markers of systemic inflammation in the Women's Health Initiative Observational Study. Nutrition 24:941–9.
116. Magrone, T., E., Jirillo, A., Spagnoletta, M., Magrone, M. A., Russo, S., Fontana, F., Laforgia, I., Donvito, A., Campanella, F., Silvestris, and G., De Pergola. 2017. Immune profile of obese people and in vitro effects of red grape polyphenols on peripheral blood mononuclear cells. Oxid Med Cell Longev 2017:9210862.
117. Maioli, T. U., J. L., Gonçalves, M. C., Miranda, V. D., Martins, L. S., Horta, T. G., Moreira, A. L., Godard, A. F., Santiago, and A. M., Faria. 2016. High sugar and butter (HSB) diet induces obesity and metabolic syndrome with decrease in regulatory T cells in adipose tissue of mice. Inflamm Res 65:169–78.
118. Manzel, A., D. N., Muller, D. A., Hafler, S. E., Erdman, R. A., Linker, and M., Kleinewietfeld. 2014. Role of “Western diet” in inflammatory autoimmune diseases. Curr Allergy Asthma Rep 14:404.
119. Marathe, C. S., C. K., Rayner, K. L., Jones, and M., Horowitz. 2013. Glucagon-like peptides 1 and 2 in health and disease: a review. Peptides 44:75–86.
120. Marchesini, G., ChP., Day, J. F., Dufour, A., Canbay, V., Nobili, V., Ratziu, H., Tilg, M., Roden, A., Gastaldelli, H., Yki-Järvinen, F., Schick, R., Vettor, G., Frühbeck, and L., Mathus-Vliegen. 2016. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 64:1388–402.
121. Margioris, A. N., 2009. Fatty acids and postprandial inflammation. Curr Opin Clin Nutr Metab Care 12:129–37.
122. Martínez-González, M. Á., M., Ruiz-Canela, A., Hruby, L., Liang, A., Trichopoulou, and F. B., Hu. 2016. Intervention trials with the mediterranean diet in cardiovascular prevention: Understanding potential mechanisms through metabolomic profiling J Nutr 146:913–9
123. Marzulli, G., T., Magrone, L., Vonghia, M., Kaneko, H., Takimoto, Y., Kumazawa, and E., Jirillo. 2014. Immunomodulating and anti-allergic effects of Negroamaro and Koshu Vitis vinifera fermented grape marc (FGM). Curr Pharm Des 20:864–8.
124. Malhi, H., and RJ., Kaufman. 2011. Endoplasmic reticulum stress in liver disease. J Hepatol 54:795–809.
125. Mebius, R. E., and G., Kraal. 2005. Structure and function of the spleen. Nat Rev Immunol 5:606–16.
126. Mena, M. P., E., Sacanella, M., Vazquez-Agell, M., Morales, M., Fitó, R., Escoda, M., Serrano-Martínez, J., Salas-Salvadó, N., Benages, R., Casas, R. M., Lamuela-Raventós, F., Masanes, E., Ros, and R., Estruch. 2009. Inhibition of circulating immune cell activation: a molecular antiinflammatory effect of the Mediterranean diet. Am J Clin Nutr 89:248–56.
127. Mikolasevic, I., S., Milic, T., Turk Wensveen, I., Grgic, I., Jakopcic, D., Stimac, F., Wensveen, and L., Orlic. 2016. Nonalcoholic fatty liver disease - A multisystem disease? World J Gastroenterol 22:9488–505.
128. Minihane, A. M., S., Vinoy, W. R., Russell, A., Baka, H. M., Roche, K. M., Tuohy, J. L., Teeling, E. E., Blaak, M., Fenech, D., Vauzour, H. J., McArdle, B. H., Kremer, L., Sterkman, K., Vafeiadou, M. M., Benedetti, C. M., Williams, and P. C., Calder. 2015. Low-grade inflammation, diet composition and health: Current research evidence and its translation. Br J Nutr 114999–1012.
129. Misciagna, G., M., Del Pilar Díaz, D. V., Caramia, C., Bonfiglio, I., Franco, M. R., Noviello, M., Chiloiro, D. I., Abbrescia, A., Mirizzi, M., Tanzi, M. G., Caruso, M., Correale, R., Reddavide, R., Inguaggiato, A. M., Cisternino, and A. R., Osella. 2017. Effect of a low glycemic index mediterranean diet on non-alcoholic fatty liver disease. A randomized controlled clinici trial. J Nutr Health Aging 21:404–12.
130. Mohanty, P., W., Hamouda, R., Garg, A., Aljada, H., Ghanim, and P., Dandona. 2000. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 85:2970–3.
131. Murotomi, K., S., Arai, S., Uchida, S., Endo, H., Mitsuzumi, Y., Tabei, Y., Yoshida, and Y., Nakajima. 2016. Involvement of splenic iron accumulation in the development of nonalcoholic steatohepatitis in Tsumura Suzuki Obese Diabetes mice. Sci Rep 6:22476.
132. Nagakura, T., S., Matsuda, K., Shichijyo, H., Sugimoto, and K., Hata. 2000. Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma. Eur Respir J 16:861–5.
133. Nagareddy, P. R., M., Kraakman, S. L., Masters, R. A., Stirzaker, D. J., Gorman, R. W., Grant, D., Dragoljevic, E. S., Hong, A., Abdel-Latif, S. S., Smyth, S. H., Choi, J., Korner, K. E., Bornfeldt, E. A., Fisher, V. D., Dixit, A. R., Tall, I. J., Goldberg, and A. J., Murphy. 2014. Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity. Cell Metab 19:821–35.
134. Nappi, F., L., Barrea, C., Di Somma, M. C., Savanelli, G., Muscogiuri, F., Orio, and S., Savastano. 2016. Endocrine aspects of environmental “Obesogen” Pollutants. Int J Environ Res Public Health 13:765–80.
135. Nasef, N. A., S., Mehta, and L. R., Ferguson. 2017. Susceptibility to chronic inflammation: an update. Arch Toxicol 91:1131–41.
136. Neale, E. P., M. J., Batterham, and L. C., Tapsell. 2016. Consumption of a healthy dietary pattern results in significant reductions in C-reactive protein levels in adults: A meta-analysis. Nutr Res 36:391–401.
137. Neustadt, J., 2006. Western diet and inflammation. Integr. Med 5:14–18.
138. Niculescu, M. D., and D. S., Lupu. 2011. Nutritional influence on epigenetics and effects on longevity. Curr Opin Clin Nutr Metab Care 14:35–40.
139. Nielsen, F. H., 2010. Magnesium, inflammation, and obesity in chronic disease. Nutr Rev 68:333–40.
140. Nitta, C. F., and R. A., Orlando. 2013. Crosstalk between immune cells and adipocytes requires both paracrine factors and cell contact to modify cytokine secretion. PLoS One 8:e77306.
141. North, C. J., C. S., Venter, and J. C., Jerling. 2009. The effects of dietary fibre on C-reactive protein, an inflammation marker predicting cardiovascular disease. Eur J Clin Nutr 63:921–33.
142. Ohki, T., A., Isogawa, M., Iwamoto, M., Ohsugi, H., Yoshida, N., Toda, K., Tagawa, M., Omata, and K., Koike. 2012. The effectiveness of liraglutide in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus compared to sitagliptin and pioglitazone. ScientificWorldJournal 2012:496453.
143. Oliviero, F., P., Spinella, U., Fiocco, R., Ramonda, P., Sfriso, and L., Punzi. 2015. How the mediterranean diet and some of its components modulate inflammatory pathways in arthritis. Swiss Med Wkly 145:w14190.
144. Pahwa, R., and I., Jialal. 2016. Hyperglycemia induces toll-like receptor activity through increased oxidative stress. Metab Syndr Relat Disord 14:239–41.
145. Paniagua, J. A., 2016. Nutrition, insulin resistance and dysfunctional adipose tissue determine the different components of metabolic syndrome. World J Diabetes 7:483–514.
146. Papamiltiadous, E. S., S. K., Roberts, A. J., Nicoll, M. C., Ryan, C., Itsiopoulos, A., Salim, and A. C., Tierney. 2016. A randomised controlled trial of a mediterranean dietary intervention for adults with non alcoholic fatty liver disease (MEDINA): Study protocol. BMC Gastroenterol 16:14.
147. Park, J. H., S. H., Kim, M. S., Lee, and M. S., Kim. 2017. Epigenetic modification by dietary factors: Implications in metabolic syndrome. Mol Aspects Med S0098-2997:30062–0.
148. Patrick, L., 2002. Nonalcoholic fatty liver disease: relationship to insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine. Altern Med Rev 7:276–91.
149. Petta, S., A., Gastaldelli, E., Rebelos, E., Bugianesi, P., Messa, L., Miele, G., Svegliati-Baroni, L., Valenti, and F., Bonino. 2016. Pathophysiology of non alcoholic fatty liver disease. Int J Mol Sci 17:2082–107.
150. Pogribny, I. P., V. P., Tryndyak, T. V., Bagnyukova, S., Melnyk, B., Montgomery, S. A., Ross, J. R., Latendresse, I., Rusyn, and F. A., Beland. 2009. Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet. J Hepatol 51:176–86.
151. Polyzos, S. A., J., Kountouras, G., Deretzi, C., Zavos, and C. S., Mantzoros. 2012. The emerging role of endocrine disruptors in pathogenesis of insulin resistance: a concept implicating nonalcoholic fatty liver disease. Curr Mol Med 12:68–82.
152. Ratziu, V., 2017. Non-pharmacological interventions in non-alcoholic fatty liver disease patients. Liver Int 37:90–96.
153. Redgrave, T. G., 2004. Chylomicron metabolism. Biochem Soc Trans 32:79–82.
154. Richards, P., R., Pais, A. M., Habib, C. A., Brighton, G. S., Yeo, F., Reimann, and F. M., Gribble. 2016. High fat diet impairs the function of glucagon-like peptide-1 producing L-cells. Peptides 77:21–7.
155. Rinella, M. E., 2015. Nonalcoholic fatty liver disease: a systematic review. JAMA 313:2263–73.
156. Ripken, D., N., van der Wielen, H. M., Wortelboer, J., Meijerink, R. F., Witkamp, and H. F., Hendriks. 2016. Nutrient-induced glucagon like peptide-1 release is modulated by serotonin. J Nutr Biochem 32:142–50.
157. Rocha, D. M., J., Bressan, and H. H., Hermsdorff. 2017. The role of dietary fatty acid intake in inflammatory gene expression: A critical review. Sao Paulo Med J 5:0.
158. Romano, K. A., E. I., Vivas, D., Amador-Noguez, and F. E., Rey. 2015. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. MBio 6:e02481.
159. Roth, C. L., C. T., Elfers, D. P., Figlewicz, S. J., Melhorn, G. J., Morton, A., Hoofnagle, M. M., Yeh, J. E., Nelson, and K. V., Kowdley. 2012. Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation. Hepatology 55:1103–11.
160. Ruiz-Núñez, B., D. A., Dijck-Brouwer, and F. A., Muskiet. 2016. The relation of saturated fatty acids with low-grade inflammation and cardiovascular disease. J Nutr Biochem 36:1–20.
161. Rusu, E., G., Enache, M., Jinga, R., Dragut, R., Nan, H., Popescu, C., Parpala, C., Homentcovschi, M., Nitescu, M., Stoian, A., Costache, M., Posea, F., Rusu, V., Jinga, D., Mischianu, and G., Radulian. 2015. Medical nutrition therapy in non-alcoholic fatty liver disease–a review of literature. J Med Life 8:258–62.
162. Ryan, M. C., C., Itsiopoulos, T., Thodis, G., Ward, N., Trost, S., Hofferberth, K., O'Dea, P. V., Desmond, N. A., Johnson, and A. M., Wilson. 2013. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol 59:138–43.
163. Samanta, S., S., Rajasingh, T., Cao, B., Dawn, and J., Rajasingh. 2017. Epigenetic dysfunctional diseases and therapy for infection and inflammation. Biochim Biophys Acta 1863:518–28.
164. Saremi, A., and R., Arora. 2009. The utility of omega-3 fatty acids in cardiovascular disease. Am J Ther 16:421–36.
165. Savastano, S., L., Barrea, M. C., Savanelli, F., Nappi, C., Di Somma, F., Orio, and A., Colao. 2017. Low vitamin D status and obesity: Role of nutritionist. Rev Endocr Metab Disord 18:215–25.
166. Savastano, S., C., Di Somma, G., Pizza, A., De Rosa, V., Nedi, A., Rossi, F., Orio, G., Lombardi, A., Colao, and G., Tarantino. 2011. Liver-spleen axis, insulin-like growth factor-(IGF)-I axis and fat mass in overweight/obese females. J Transl Med 9:136.
167. Schwingshackl, L., and G., Hoffmann. 2014. Mediterranean dietary pattern, inflammation and endothelial function: A systematic review and meta-analysis of intervention trials. Nutr Metab Cardiovasc Dis 24:929–39.
168. Semaeva, E., O., Tenstad, J., Skavland, M., Enger, P. O., Iversen, B. T., Gjertsen, and H., Wiig. 2010. Access to the spleen microenvironment through lymph shows local cytokine production, increased cell flux, and altered signaling of immune cells during lipopolysaccharide-induced acute inflammation. J Immunol 184:4547–56.
169. Seydel, S., A., Beilfuss, A., Kahraman, K., Aksoy, G., Gerken, H., Akkiz, and A., Canbay. 2011. Vitamin D ameliorates stress ligand expression elicited by free fatty acids in the hepatic stellate cell line LX-2. Turk J Gastroenterol 22:400–7.
170. Shah, M. S., and M., Brownlee. 2016. Molecular and cellular mechanisms of cardiovascular disorders in diabetes. Circ Res 118:1808–29.
171. Shivappa, N., J. R., Hebert, A., Marcos, L. E., Diaz, S., Gomez, E., Nova, N., Michels, A., Arouca, E., González-Gil, G., Frederic, M., González-Gross, M. J., Castillo, Y., Manios, M., Kersting, M. J., Gunter, S., De Henauw, K., Antonios, K., Widhalm, D., Molnar, L., Moreno, and I., Huybrechts. 2017. Association between dietary inflammatory index and inflammatory markers in the HELENA study. Mol Nutr Food Res 61:1–10.
172. Simopoulos, A. P., 2016. An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity. Nutrients 8:128.
173. Singh, S., A. M., Allen, Z., Wang, L. J., Prokop, M. H., Murad, and R., Loomba. 2015. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol 13:643–54.
174. Siriwardhana, N., N. S., Kalupahana, M., Cekanova, M., LeMieux, B., Greer, and N., Moustaid-Moussa. 2013. Modulation of adipose tissue inflammation by bioactive food compounds. J Nutr Biochem 24:613–23.
175. Soeki, T., and M., Sata. 2016. Inflammatory Biomarkers and Atherosclerosis. Int Heart J 57:134–9.
176. Soni, N. K., A. B., Ross, N., Scheers, O. I., Savolainen, I., Nookaew, B. G., Gabrielsson, and A. S., Sandberg. 2017. Splenic immune response is down-regulated in C57BL/6J Mice fed eicosapentaenoic acid and docosahexaenoic acid enriched high fat diet. Nutrients 9:50–66.
177. Steckhan, N., C. D., Hohmann, C., Kessler, G., Dobos, A., Michalsen, and H., Cramer. 2016. Effects of different dietary approaches on inflammatory markers in patients with metabolic syndrome: A systematic review and meta-analysis. Nutrition 32:338–48.
178. Sullivan, K. E., A. B., Reddy, K., Dietzmann, A. R., Suriano, V. P., Kocieda, M., Stewart, and M., Bhatia. 2007. Epigenetic regulation of tumor necrosis factor alpha. Mol Cell Biol 27:5147–60.
179. Sun, S. Z., and M. W., Empie. 2012. Fructose metabolism in humans - what isotopic tracer studies tell us. Nutr Metab (Lond) 989.
180. Suzuki, K., H., Kirikoshi, M., Yoneda, H., Mawatari, K., Fujita, Y., Nozaki, H., Takahashi, Y., Abe, M., Inamori, T., Shimamura, N., Kobayashi, K., Kubota, S., Saito, and A., Nakajima. 2010. Measurement of spleen volume is useful for distinguishing between simple steatosis and early-stage non-alcoholic steatohepatitis. Hepatol Res 40:693–700.
181. Svahn, S. L., L., Väremo, B. G., Gabrielsson, E., Peris, I., Nookaew, L., Grahnemo, A. S., Sandberg, I., Wernstedt Asterholm, J. O., Jansson, J., Nielsen, and M. E., Johansson. 2016. Six Tissue Transcriptomics Reveals Specific Immune Suppression in Spleen by Dietary Polyunsaturated Fatty Acids. PLoS One 11:e0155099.
182. Swirski, F. K., M., Nahrendorf, M., Etzrodt, M., Wildgruber, V., Cortez-Retamozo, P., Panizzi, J. L., Figueiredo, R. H., Kohler, A., Chudnovskiy, P., Waterman, E., Aikawa, T. R., Mempel, P., Libby, R., Weissleder, and M. J., Pittet. 2009. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325:612–6.
183. Szarc vel Szic, K., K., Declerck, M., Vidaković, and W., Vanden Berghe. 2015. From inflammaging to healthy aging by dietary lifestyle choices: Is epigenetics the key to personalized nutrition? Clin Epigenetics 7:33.
184. Tam, M., S., Gómez, M., González-Gross, and A., Marcos. 2003. Possible roles of magnesium on the immune system. Eur J Clin Nutr 57:1193–7.
185. Tarantino, G., P., Colicchio, P., Conca, C., Finelli, M. N., Di Minno, M., Tarantin, D., Capone, and F., Pasanisi. 2009a. Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively? J Inflamm (Lond) 6:6.
186. Tarantino, G., P., Conca, F., Pasanisi, M., Ariello, M., Mastrolia, A., Arena, M., Tarantino, F., Scopacasa, and R., Vecchione. 2009b. Could inflammatory markers help diagnose nonalcoholic steatohepatitis? Eur J Gastroenterol Hepatol 21:504–11.
187. Tarantino, G., S., Savastano, D., Capone, and A., Colao. 2011. Spleen: A new role for an old player? World J Gastroenterol 17:3776–84.
188. Tarantino, G., A., Scalera, and C., Finelli. 2013. Liver-spleen axis: intersection between immunity, infections and metabolism. World J Gastroenterol 19:3534–42.
189. Tarantino, G., R., Valentino, C., Di Somma, V., D'Esposito, F., Passaretti, G., Pizza, V., Brancato, F., Orio, P., Formisano, A., Colao, and S., Savastano. 2013. Bisphenol A in polycystic ovary syndrome and its association with liver-spleen axis. Clin Endocrinol (Oxf) 78:447–53.
190. Teeman, C. S., S. P., Kurti, B. J., Cull, S. R., Emerson, M. D., Haub, and S. K., Rosenkranz. 2016. Postprandial lipemic and inflammatory responses to high-fat meals: a review of the roles of acute and chronic exercise. Nutr Metab (Lond) 13:80.
191. Trichopoulou, A., M. A., Martínez-González, T. Y., Tong, N. G., Forouhi, S., Khandelwal, D., Prabhakaran, D., Mozaffarian, and M., de Lorgeril. 2014. Definitions and potential health benefits of the Mediterranean diet: views from experts around the world. BMC Med 12:112.
192. Trovato, F. M., D., Catalano, G. F., Martines, P., Pace, and G. M., Trovato. 2015. Mediterranean diet and non-alcoholic fatty liver disease: the need of extended and comprehensive interventions. Clin Nutr 34:86–8.
193. Trovato, F. M., G. F., Martines, D., Brischetto, G., Trovato, and D., Catalano. 2016. Neglected features of lifestyle: Their relevance in non-alcoholic fatty liver disease. World J Hepatol 8:1459–65.
194. Trummer, C., M., Pandis, N., Verheyen, M. R., Grübler, M., Gaksch, B., Obermayer-Pietsch, A., Tomaschitz, T. R., Pieber, S., Pilz, and V., Schwetz. 2016. Beneficial effects of UV-radiation: Vitamin D and beyond. Int J Environ Res Public Health 13:1028–43.
195. Tsushima, Y., and K., Endo. 2000. Spleen enlargement in patients with nonalcoholic fatty liver: correlation between degree of fatty infiltration in liver and size of spleen. Dig Dis Sci 45:196–200.
196. Vaiserman, A. M., 2017. Early-life nutritional programming of Type 2 Diabetes: Experimental and quasi-experimental evidence. Nutrients 9:pii: E236.
197. Valenti, L., E., Bugianesi, U., Pajvani, and G., Targher. 2016. Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes? Liver Int 36:1563–79.
198. van der Veeken, J., A. J., Gonzalez, H., Cho, A., Arvey, S., Hemmers, C. S., Leslie, and A. Y., Rudensky. 2016. Memory of inflammation in regulatory T cells. Cell 166:977–90.
199. van der Voort, E. A., E. M., Koehler, E. A., Dowlatshahi, A., Hofman, B. H., Stricker, H. L., Janssen, J. N., Schouten, and T., Nijsten. 2014. Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study. J Am Acad Dermatol 70:517–24.
200. Velasco, N., A., Contreras, and B., Grassi. 2014. The Mediterranean diet, hepatic steatosis and nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care 17:453–7.
201. Veronese, N., S., Watutantrige-Fernando, C., Luchini, M., Solmi, G., Sartore, G., Sergi, E., Manzato, M., Barbagallo, S., Maggi, and B., Stubbs. 2016. Effect of magnesium supplementation on glucose metabolism in people with or at risk of diabetes: a systematic review and meta-analysis of double-blind randomized controlled trials. Eur J Clin Nutr 70:1354–59.
202. Vici, G., L., Belli, M., Biondi, and V., Polzonetti. 2016. Gluten free diet and nutrient deficiencies: A review. Clin Nutr 35:1236–41.
203. Wang, H., Q., Zhang, Y., Chai, Y., Liu, F., Li, B., Wang, C., Zhu, J., Cui, H., Qu, and M., Zhu. 2015. 1,25(OH)2D3 downregulates the Toll-like receptor 4-mediated inflammatory pathway and ameliorates liver injury in diabetic rats. J Endocrinol Invest 38:1083–91.
204. Wang, J., Z., Wu, D., Li, N., Li, S. V., Dindot, M. C., Satterfield, F. W., Bazer, and G., Wu. 2012. Nutrition, epigenetics, and metabolic syndrome. Antioxid Redox Signal 17:282–301.
205. Wang, X. C., A. M., Gusdon, H., Liu, and S., Qu. 2014. Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammation. World J Gastroenterol 20:14821–30.
206. Watts, G. F., 2010. Nutrition and metabolism: nutritional therapy for disordered triglyceride metabolism and nonalcoholic fatty liver disease. Curr Opin Lipidol 21:545–7.
207. Weisberg, S. P., D., McCann, M., Desai, M., Rosenbaum, R. L., Leibel, and A. W., Ferrante Jr. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796–808.
208. Wong, B. W., A., Meredith, D., Lin, and B. M., McManus. 2012. The biological role of inflammation in atherosclerosis. Can J Cardiol 28:631–41.
209. Xue, S., C. H., Wasserfall, M., Parker, T. M., Brusko, S., McGrail, K., McGrail, M., Moore, M., Campbell-Thompson, D. A., Schatz, M. A., Atkinson, and M. J., Haller. 2008. Exendin-4 therapy in NOD mice with new-onset diabetes increases regulatory T cell frequency. Ann N Y Acad Sci 1150:152–6.
210. Yashodhara, B. M., S., Umakanth, J. M., Pappachan, S. K., Bhat, R., Kamath, and B. H., Choo. 2009. Omega-3 fatty acids: a comprehensive review of their role in health and disease. Postgrad Med J 85:84–90.
211. Yates, C. M., P. C., Calder, G., Ed Rainger. 2014. Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease. Pharmacol Ther 141:272–82.
212. Yu, J., S., Marsh, J., Hu, W., Feng, and C., Wu. 2016. The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background. Gastroenterol Res Pract 2016:2862173.
213. Zelber-Sagi, S., F., Salomone, and L., Mlynarsky. 2017. The Mediterranean dietary pattern as the diet of choice for NAFLD; evidence and plausible mechanisms. Liver Int 37:936–49.
214. Zeng, H., and H., Chi. 2015. Metabolic control of regulatory T cell development and function. Trends Immunol 36:3–12.
215. Zhang, H., Y., Xue, H., Wang, Y., Huang, R. J., McCormick, W. J., Means, M., Du, and M., Zhu. 2013. Mast cell deficiency induces inflammation and exacerbates inflammatory bowel symptoms in IL10−/− mice. The FASEB Journal 27:137–45
216. Zhang, P. Y., 2015. Polyphenols in Health and Disease. Cell Biochem Biophys 73:649–64.